Ludwig G, Pauthner H
Department of Urology, Stadt-Krankenhaus Höchst, Frankfurt am Main.
Drugs. 1987;34 Suppl 1:95-9. doi: 10.2165/00003495-198700341-00021.
The efficacy and tolerance of ofloxacin were compared with those of co-trimoxazole in upper urinary tract infections (UTIs) and nitrofurantoin in lower UTIs in a prospective, controlled, randomised, observer-blind study. Ofloxacin proved to be an effective and well-tolerated substance. The clinical cure rate was more pronounced than that of both comparative drugs and ofloxacin was also superior to co-trimoxazole and nitrofurantoin in terms of bacterial elimination. A second, controlled study showed that single doses of ofloxacin 100mg were clinically and bacteriologically as effective as a 3-day course of ofloxacin 100mg twice daily in women with uncomplicated lower UTIs.
在一项前瞻性、对照、随机、观察者盲法研究中,比较了氧氟沙星与复方新诺明在上尿路感染(UTIs)中的疗效及耐受性,以及与呋喃妥因在下尿路感染中的疗效及耐受性。结果证明氧氟沙星是一种有效且耐受性良好的药物。其临床治愈率比两种对照药物都更显著,并且在细菌清除方面,氧氟沙星也优于复方新诺明和呋喃妥因。另一项对照研究表明,对于患有单纯性下尿路感染的女性,单剂量100mg氧氟沙星在临床和细菌学上与每日两次服用100mg氧氟沙星、疗程为3天的效果相同。